微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 61.72% | -19.96% | -4.57% | 52/141 | 52.4% | 佰仁医疗科技 | 88.71% | 行业排名> |
| 2026-03-31 | 64.68% | -14.86% | -10.39% | 39/141 | 52.37% | 佰仁医疗科技 | 88.17% | 行业排名> |
| 2025-12-31 | 72.17% | 19.88% | -2.61% | 17/141 | 51.9% | 佰仁医疗科技 | 89.18% | 行业排名> |
| 2025-09-30 | 74.11% | 50.99% | -3.9% | 13/141 | 52.23% | 佰仁医疗科技 | 88.17% | 行业排名> |
| 2025-06-30 | 77.11% | 61.39% | 1.51% | 11/141 | 52.48% | 佰仁医疗科技 | 88.54% | 行业排名> |
| 2025-03-31 | 75.96% | 73.67% | 26.17% | 15/141 | 52.13% | 佰仁医疗科技 | 85.72% | 行业排名> |
| 2024-12-31 | 60.2% | 17.14% | 22.67% | 57/141 | 53.08% | 佰仁医疗科技 | 88.34% | 行业排名> |
| 2024-09-30 | 49.08% | -3.49% | 2.72% | 77/141 | 53.87% | 佰仁医疗科技 | 88.56% | 行业排名> |
| 2024-06-30 | 47.78% | -15.17% | 9.24% | 82/141 | 53.95% | 佰仁医疗科技 | 89.27% | 行业排名> |
| 2024-03-31 | 43.74% | -27.43% | -14.9% | 83/141 | 53.88% | 佰仁医疗科技 | 89.28% | 行业排名> |
| 2023-12-31 | 51.39% | -12.85% | 1.06% | 73/141 | 53.57% | 正海生物 | 89.9% | 行业排名> |
| 2023-09-30 | 50.85% | -17.13% | -9.72% | 73/141 | 54.44% | 正海生物 | 90.39% | 行业排名> |
| 2023-06-30 | 56.33% | -9.86% | -6.55% | 64/141 | 53.81% | 正海生物 | 90.3% | 行业排名> |
| 2023-03-31 | 60.28% | 5.06% | 2.21% | 55/141 | 54.06% | 万泰生物 | 91.61% | 行业排名> |
| 2022-12-31 | 58.97% | 5.74% | -3.91% | 58/141 | 54.01% | 三友医疗 | 90.18% | 行业排名> |
| 2022-09-30 | 61.37% | 20.43% | -1.79% | 50/141 | 55.7% | 三友医疗 | 90.14% | 行业排名> |
| 2022-06-30 | 62.49% | 12.66% | 8.92% | 51/141 | 55.37% | 三友医疗 | 90.29% | 行业排名> |
| 2022-03-31 | 57.37% | 3.94% | 2.87% | 64/141 | 56.89% | 三友医疗 | 90.73% | 行业排名> |
| 2021-12-31 | 55.77% | 19.07% | 9.44% | 77/141 | 57.98% | 三友医疗 | 90.5% | 行业排名> |
| 2021-09-30 | 50.96% | 6.66% | -8.13% | 73/141 | 59.77% | 三友医疗 | 90.29% | 行业排名> |
| 2021-06-30 | 55.47% | 17.8% | 0.49% | 73/141 | 59.05% | 正海生物 | 90.78% | 行业排名> |
| 2021-03-31 | 55.2% | 24.1% | 17.85% | 66/141 | 61.5% | 正海生物 | 91.59% | 行业排名> |
| 2020-12-31 | 46.84% | 0.71% | -1.96% | 95/141 | 60.12% | 正海生物 | 92.23% | 行业排名> |
| 2020-09-30 | 47.77% | 10.01% | 1.47% | 69/141 | 62.21% | 正海生物 | 92.69% | 行业排名> |
| 2020-06-30 | 47.08% | 1.7% | 5.86% | 85/141 | 60.36% | 正海生物 | 92.61% | 行业排名> |
| 2020-03-31 | 44.48% | 14.07% | -4.36% | 55/141 | 58.8% | 正海生物 | 94.38% | 行业排名> |
| 2019-12-31 | 46.51% | -16.71% | 7.09% | 80/141 | 56.96% | 正海生物 | 93.12% | 行业排名> |
| 2019-09-30 | 43.43% | -31.73% | -6.2% | 48/141 | 55.83% | 正海生物 | 93.78% | 行业排名> |
| 2019-06-30 | 46.3% | -31.59% | 18.73% | 49/141 | 57.93% | 正海生物 | 93.09% | 行业排名> |
| 2019-03-31 | 38.99% | -38.4% | -30.17% | 41/141 | 52.61% | 正海生物 | 93.85% | 行业排名> |
| 2018-12-31 | 55.84% | -27.67% | -12.21% | 59/141 | 56.22% | 正海生物 | 93.08% | 行业排名> |
| 2018-09-30 | 63.61% | -19.84% | -6.02% | 20/141 | 52.76% | 正海生物 | 92.83% | 行业排名> |
| 2018-06-30 | 67.68% | -15.93% | 6.92% | 22/141 | 53.06% | 正海生物 | 92.44% | 行业排名> |
| 2018-03-31 | 63.3% | -19.8% | -18.01% | 19/141 | 52.55% | 正海生物 | 92.7% | 行业排名> |
| 2017-12-31 | 77.2% | 2.22% | -2.7% | 18/141 | 56.1% | 正海生物 | 93.67% | 行业排名> |
| 2017-09-30 | 79.35% | 2.51% | -1.43% | 8/141 | 53.53% | 正海生物 | 94.14% | 行业排名> |
| 2017-06-30 | 80.5% | 4.11% | 2.01% | 10/141 | 54.85% | 正海生物 | 93.83% | 行业排名> |
| 2017-03-31 | 78.92% | 0.8% | 4.49% | 6/141 | 54.29% | 正海生物 | 93.69% | 行业排名> |
| 2016-12-31 | 75.53% | -1.62% | -2.43% | 17/141 | 57.35% | 正海生物 | 92.79% | 行业排名> |
| 2016-09-30 | 77.41% | 0.24% | 0.11% | 3/141 | 51.85% | 健帆生物 | 84.23% | 行业排名> |
| 2016-06-30 | 77.32% | -0.05% | -1.23% | 6/141 | 52.6% | *ST明德 | 86.71% | 行业排名> |
| 2016-03-31 | 78.29% | -1% | 1.98% | 2/141 | 50.24% | 健帆生物 | 83.86% | 行业排名> |